Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. E.G.E. (Elisabeth) de Vries
University Medical Center Groningen

prof. dr. E.G.E. (Elisabeth) de Vries

No picture available


Other positions

Member of the Royal Netherlands Academy of Arts and Sciences (KNAW) since 2002; Member supervisory board of the Netherlands Comprehensive Cancer organisation (IKNL), 2015-present; Member European Society of Medical Oncology (ESMO)-Magnitude of Clinical Benefit Scale (MCBS) working group, 2013-present; Member and since 2017 chair ESMO Cancer Medicines Working Group, 2015-present; Co-Chair RECIST committee, 2009-present; Member and since 2021 chair scientific advisory board, 2018-present; Chair WHO Essential Medicines List Cancer Working Group, 2021; Member Expert panel for selection of Essential Medicine List WHO, 2019 and 2021; Member Strategic Advisory Board (SAB) National Cancer Imaging Translational Accelerator (NCITA) Award, 2019-current. Member ESMO guideline committee, steering committee member, 2015-2019; Member Governing Body European Academy of Cancer Sciences, 2010-2018; Member Cancer Research UK’s Centre Network Accelerator Award (CNAA) panel, 2016-current; Chair Grant Selection Exploration Committee Dutch Cancer Society, 2016-2020; Member domain jury ‘Levens-, Aard- en Milieuwetenschappen’, Royal Netherlands Academy of Arts and Sciences (KNAW) , 2014-2020. PI: Alpe d’HuZes grant IMPACT, Dutch Cancer Society grant POINTING, Dutch Cancer Society grant N-CIA, IMI TRISTAN, IMI Immune-Image. In the past 3 years Institutional Financial Support for Advisory Boards of NSABP, Daiichi Sankyo, and Crescendo Biologics; Institutional Financial Support for contracted research or clinical trials of Amgen, Bayer, Crescendo Biologics, CytomX Therapeutics, G1 Therapeutics, Roche, Genentech, Servier, Synthon, Regeneron.
Last modified:01 March 2024 11.38 a.m.

Contact information

Antonius Deusinglaan 1
9713 AV Groningen
The Netherlands